DSGN
Price
$5.16
Change
-$0.10 (-1.90%)
Updated
Aug 25, 11:18 AM (EDT)
Capitalization
299.55M
72 days until earnings call
PBYI
Price
$5.00
Change
-$0.24 (-4.57%)
Updated
Aug 25, 11:57 AM (EDT)
Capitalization
264.45M
66 days until earnings call
Interact to see
Advertisement

DSGN vs PBYI

Header iconDSGN vs PBYI Comparison
Open Charts DSGN vs PBYIBanner chart's image
Design Therapeutics
Price$5.16
Change-$0.10 (-1.90%)
Volume$100
Capitalization299.55M
Puma Biotechnology
Price$5.00
Change-$0.24 (-4.57%)
Volume$100
Capitalization264.45M
DSGN vs PBYI Comparison Chart in %
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. PBYI commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a StrongBuy and PBYI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (DSGN: $5.26 vs. PBYI: $5.25)
Brand notoriety: DSGN and PBYI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 153% vs. PBYI: 116%
Market capitalization -- DSGN: $299.55M vs. PBYI: $264.45M
DSGN [@Biotechnology] is valued at $299.55M. PBYI’s [@Biotechnology] market capitalization is $264.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whilePBYI’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • PBYI’s FA Score: 1 green, 4 red.
According to our system of comparison, PBYI is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 5 TA indicator(s) are bullish while PBYI’s TA Score has 5 bullish TA indicator(s).

  • DSGN’s TA Score: 5 bullish, 4 bearish.
  • PBYI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than PBYI.

Price Growth

DSGN (@Biotechnology) experienced а -1.31% price change this week, while PBYI (@Biotechnology) price change was -8.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.86%. For the same industry, the average monthly price growth was +19.74%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

DSGN is expected to report earnings on Nov 05, 2025.

PBYI is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($300M) has a higher market cap than PBYI($264M). PBYI YTD gains are higher at: 72.131 vs. DSGN (-14.749). PBYI has higher annual earnings (EBITDA): 63.3M vs. DSGN (-74.31M). DSGN has more cash in the bank: 216M vs. PBYI (96M). DSGN has less debt than PBYI: DSGN (1.95M) vs PBYI (49.2M). PBYI has higher revenues than DSGN: PBYI (238M) vs DSGN (0).
DSGNPBYIDSGN / PBYI
Capitalization300M264M114%
EBITDA-74.31M63.3M-117%
Gain YTD-14.74972.131-20%
P/E RatioN/A5.30-
Revenue0238M-
Total Cash216M96M225%
Total Debt1.95M49.2M4%
FUNDAMENTALS RATINGS
PBYI: Fundamental Ratings
PBYI
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
17
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNPBYI
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 25 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEMHF56.460.46
+0.82%
Siemens Healthineers AG
AXFOY27.24N/A
N/A
Axfood AB
DIMC38.50-0.04
-0.10%
Dimeco, Inc.
MEQYF144.67-0.83
-0.57%
Mainstreet Equity Corp.
PKKFF0.03N/A
-2.94%
TENET FINTECH GROUP INC.

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
+2.14%
VRDN - DSGN
50%
Loosely correlated
+6.69%
IDYA - DSGN
49%
Loosely correlated
+1.99%
TRDA - DSGN
47%
Loosely correlated
+4.60%
AURA - DSGN
47%
Loosely correlated
+1.24%
CRNX - DSGN
45%
Loosely correlated
+5.17%
More